APA (7th ed.) Citation

He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., . . . Zhou, D. (2020). Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies. Journal of Hematology & Oncology, 13(1), 1. https://doi.org/10.1186/s13045-020-00924-z

Chicago Style (17th ed.) Citation

He, Yonghan, et al. "Proteolysis Targeting Chimeras (PROTACs) Are Emerging Therapeutics for Hematologic Malignancies." Journal of Hematology & Oncology 13, no. 1 (2020): 1. https://doi.org/10.1186/s13045-020-00924-z.

MLA (9th ed.) Citation

He, Yonghan, et al. "Proteolysis Targeting Chimeras (PROTACs) Are Emerging Therapeutics for Hematologic Malignancies." Journal of Hematology & Oncology, vol. 13, no. 1, 2020, p. 1, https://doi.org/10.1186/s13045-020-00924-z.